JBS S.A. Earnings Call Highlights Record Growth

Jbs S.A. ((JBS)) has held its Q4 earnings call. Read on for the main highlights of the call.

JBS S.A. struck an upbeat tone on its latest earnings call, underscoring record sales, solid margins and strong returns even as it acknowledged meaningful short‑term headwinds. Management highlighted resilient global demand, robust liquidity and conservative leverage as key buffers against U.S. beef supply tightness, feed inflation and external trade and labor risks.

Record Revenue and Sales Growth

Net sales climbed to a record $23.0 billion in Q4 and $86.0 billion for FY2025, marking the highest annual revenue in the company’s history. This represented 13% year‑over‑year growth, signaling broad‑based demand strength across geographies and product lines despite a volatile commodity backdrop.

EBITDA Strength and Margin Resilience

Adjusted EBITDA under IFRS reached $1.7 billion in Q4, a 7.4% margin, and $6.8 billion for 2025 with a 7.9% margin, confirming solid profitability. On a U.S. GAAP basis, adjusted EBITDA was $1.5 billion in Q4 and $5.8 billion for the year, with margins of 6.5% and 6.7% respectively.

Earnings Growth and Rising EPS

Net income came in at $415 million in Q4 and $2.0 billion for FY2025, reflecting roughly 15% year‑over‑year growth in the bottom line. Reported EPS reached $0.39 for the quarter and $1.89 for the year, indicating that profit growth is keeping pace with the company’s rapid expansion in sales.

Free Cash Flow and Liquidity Cushion

Free cash flow rose to $990 million in Q4, up from $906 million a year earlier, although full‑year FCF was a modest $400 million given heavy investment and working‑capital use. Even so, JBS finished the year with $4.8 billion in cash and $3.5 billion in available revolving credit, providing ample funding flexibility.

High Returns and Controlled Leverage

Return on equity reached an impressive 25% while return on invested capital came in at 17%, highlighting efficient use of capital. Net debt to EBITDA closed the year at 2.39x, comfortably within the company’s 2.0–3.0x target band and signaling disciplined balance‑sheet management.

Long-Dated, Mostly Fixed Debt Profile

Management emphasized a robust liability structure, with average debt maturities of roughly 15 years and an average cost of around 5.7%. Approximately 90% of debt is at fixed rates, there are no significant maturities until 2031, and about 32% of gross debt extends beyond 2052, reducing refinancing risk.

Capital Allocation and Dividends

The company confirmed a $1.00 per share dividend payable in June, consistent with its goal of returning roughly $1 billion per year to shareholders. At the same time, JBS executed $1.1 billion of expansion CapEx in 2025, showing a willingness to invest for growth while preserving steady cash returns.

Regional Outperformance and Brand Momentum

Australia delivered standout performance with around 30% year‑over‑year top‑line growth in Q4 and margin expansion, while Brazil beef sales grew roughly 26% and processed a record 42 million heads. In branded products, Pilgrim’s Just Bare surpassed $1 billion in retail sales, illustrating the strength of value‑added offerings.

Dual Listing Boosts Trading and Valuation

Following completion of its dual listing in 2025, average trading volume has roughly tripled compared with the prior single listing. U.S. investors now represent about 70% of the free float and market multiples have expanded, although management noted JBS still trades at a discount to global peers.

U.S. Beef Supply Constraints and Volatility

Executives warned that the U.S. cattle cycle remains tight, with limited livestock availability, high input costs and periods of negative processing spreads early in the year. These conditions are expected to persist, keeping volumes constrained and causing significant swings in beef processing margins.

Working Capital and Deferred Livestock Effects

Working‑capital consumption totaled around $850 million in 2025, driven in part by timing effects from deferred livestock and inventory adjustments. While Q4 benefited from these dynamics, management cautioned that they shift reported cash flow between quarters, with a roughly $200 million phasing impact between Q4 and Q1.

CapEx-Driven Cash Pressure

Despite record revenue, full‑year free cash flow was just $400 million as expansion CapEx ran about $100 million above initial plans to roughly $1.1 billion. The company framed this spending as strategic capacity and efficiency investment but acknowledged that it weighed on near‑term cash generation.

Feed Cost and Commodity Exposure

Management expects upward pressure on corn and other feed costs in 2026 due to tighter global balances, fertilizer constraints and weather uncertainty. Since feed accounts for roughly 50–60% of poultry production costs, rising prices could squeeze margins if not offset by pricing or productivity gains.

Trade, Health and Geopolitical Risks

The call highlighted ongoing external risks, including uncertainty around China quotas, avian influenza related export suspensions and temporary closures in Mexico cattle imports. Geopolitical tensions that disrupt freight routes could also affect volumes and pricing, introducing another layer of volatility to global operations.

Derivatives and Market Volatility Impacts

Non‑operational derivatives were negatively affected by recent currency and commodity swings, leading to a weaker derivatives line in the quarter. Management stressed that overall value‑at‑risk exposure remains limited, but acknowledged that such volatility can still impact reported earnings.

Labor and Union Risks in U.S. Plants

Union negotiations at certain U.S. plants were flagged as a material operational risk, with the potential for strikes and disruptions. Any prolonged labor action could hit capacity utilization and profitability in U.S. beef operations, adding to the sector’s existing supply challenges.

Valuation Discount Versus Global Peers

Even after the dual listing and some multiple expansion, JBS still trades below the valuation levels of comparable global protein companies. Management suggested that potential future index inclusions and improving liquidity could help narrow the gap, but stressed this is not assured.

Guidance and 2026 Financial Framework

Looking ahead, JBS outlined 2026 planning assumptions that include $2.4 billion in CapEx split between $1.3 billion for expansion and $1.1 billion for maintenance, alongside interest expense of $1.15 billion and lease costs of $500 million. The company targets a 25% effective tax rate, a net‑debt to EBITDA range of 2–3x and says EBITDA of about $5.7 billion would be cash‑flow breakeven if working‑capital usage matches 2025.

JBS’s earnings call painted a picture of a protein giant balancing strong growth and shareholder returns with a candid view of sector volatility and risk. Record revenue, healthy margins and a fortress‑like balance sheet underpin management’s confidence, while investors will watch closely how the company navigates U.S. beef constraints, cost inflation and external shocks in the year ahead.